Search research articles
Contact Us
Filters
Showing results (241-250 of 243) with videos related to
Page
of 25
Sort By:
You have reached the last page of results.
This site can display upto 243 results.
Rheumatology (Oxford, England)
|
June 3, 2025
Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort
Stefano Di Donato, John D Pauling, Sheila Ramjug, et al.
The Lancet. Diabetes & Endocrinology
|
April 26, 2026
Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial
Emma G Wilmot, Patrick Moore, Thozhukat Sathyapalan, et al.
Lancet (London, England)
|
August 25, 2022
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
Solomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Page
of 25
Search research articles
Search
Showing results (241-250 of 243) with videos related to
Sort By:
Page
of 25
You have reached the last page of results.
This site can display upto 243 results.
Rheumatology (Oxford, England)
|
June 3, 2025
Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort
Stefano Di Donato, John D Pauling, Sheila Ramjug, et al.
The Lancet. Diabetes & Endocrinology
|
April 26, 2026
Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial
Emma G Wilmot, Patrick Moore, Thozhukat Sathyapalan, et al.
Lancet (London, England)
|
August 25, 2022
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
Solomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Page
of 25